POOR ADHERENCE TO TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION IS ASSOCIATED WITH GREATER HEALTH CARE COSTS

被引：0
|
作者：
Baran, R. W. [1 ]
Bhor, M. [1 ]
Laitinen, D. [1 ]
Dietz, B. [2 ]
机构：
[1] Abbott Labs Inc, Abbott Pk, IL USA
[2] Abbott GmbH & Co, Ludwigshafen, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75082-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A421 / A421
页数：1
相关论文
共 50 条
  • [1] POOR ADHERENCE TO TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION IS ASSOCIATED WITH DETRIMENTAL HEALTH OUTCOMES
    Baran, Robert W.
    Bhor, Menaka
    Dietz, Birgitta
    Laitinen, David
    HEPATOLOGY, 2009, 50 (04) : 653A - 653A
  • [2] Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C
    Adams, Shelly
    Ostermeier, Mark
    OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2010, 81 (11) : 580 - 586
  • [3] Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?
    Floreani, A
    Minola, E
    Carderi, I
    Ferrara, F
    Rizzotto, ER
    Baldo, V
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (03) : 549 - 550
  • [4] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [5] Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: A case report
    Tomasiewicz, K
    Modrzewska, R
    Semczuk, G
    ADVANCES IN THERAPY, 2006, 23 (01) : 139 - 142
  • [6] Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: A case report
    Krzysztof Tomasiewicz
    Romana Modrzewska
    Grażyna Semczuk
    Advances in Therapy, 2006, 23
  • [7] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [8] Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin
    Weiss, J. J.
    Bhatti, L.
    Dieterich, D. T.
    Edlin, B. R.
    Fishbein, D. A.
    Goetz, M. B.
    Yu, K.
    Wagner, G. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 289 - 293
  • [9] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [10] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
12345